Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06679374 · ClinicalTrials.gov registry record · Phase 2

Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease

A Phase 2 study of Parkinson Disease, sponsored by Vikas Kotagal.

Recruiting
Registry status
Phase 2
Development phase
102
Enrollment target
1
Study location

NCT06679374 is a Phase 2 study of Parkinson Disease that is actively recruiting participants, run by Vikas Kotagal. The registered enrollment target is 102 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06679374, a Phase 2 study of Parkinson Disease, is actively recruiting participants, sponsored by Vikas Kotagal.

RECRUITING
Registry status
Phase 2
Development phase
102 participants
Enrollment target
1
Study location

Study Summary

This trial aims to test whether one year of Varenicline, when compared to placebo, can reduce fall risk and show improvement in the ability to multitask while walking. Participants that are eligible after screening for the study will be randomized to receive Varenicline or placebo. Along with the study medication participants will have visits (over the phone and in person), various tests and imaging, questionnaires, and laboratory collections.

Conditions Studied

Parkinson Disease

Interventions

  • DRUG Placebo
  • DRUG Varenicline

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2025-04-09
Est. Completion 2027-01
Phase Phase 2

Sponsor

Vikas Kotagal

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06679374

The ClinicalTrials.gov registry entry for NCT06679374 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The listed sponsor is Vikas Kotagal, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06679374 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06679374 about?

NCT06679374 is a clinical study titled "Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease". This trial aims to test whether one year of Varenicline, when compared to placebo, can reduce fall risk and show improvement in the ability to multitask while walking. Participants that are eligible after screening for the study will be randomized to receive Varenicline or placebo. Along with the s...

What is the current status of trial NCT06679374?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 102 participants. The study started on 2025-04-09. Estimated completion is 2027-01.

What conditions does trial NCT06679374 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06679374?

The interventions under investigation include: Placebo (DRUG), Varenicline (DRUG).

Who is sponsoring clinical trial NCT06679374?

This trial is sponsored by Vikas Kotagal, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06679374 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.